Evidence map›Paper›PMID 36136303›Full record

ReviewEuropean heart journal2022

Sex differences in arterial hypertension.

Eva Gerdts, Isabella Sudano, Sofie Brouwers, Claudio Borghi, Rosa Maria Bruno, Claudio Ceconi, Véronique Cornelissen, François Diévart, Marc Ferrini, Thomas Kahan and 7 more

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in European heart journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07206303 (The Effects of Bifidobacterium-based Probiotics in Reducing Blood Pressure in Middle-aged Chinese With Hypertension), which is not on this map. Cited by 113 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 4 pooled it
32.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07206303 phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Effects of Bifidobacterium-based Probiotics in Reducing Blood Pressure in Middle-aged Chinese With Hypertension: a Single-term Feasibility Pilot Study

TypeinterventionalSponsorThe University of Hong KongRan2026 to 2027Enrolled30ConditionsHypertensionArmsBifidobacterium probiotics supplementation
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 4 syntheses or guidelines pooled it, 213 citations in OpenAlex.

  1. Associations of exposure to PMBMC public health · 2025
    Pooled it
  2. Pooled it
  3. Brazilian Guideline on Menopausal Cardiovascular Health - 2024.Arquivos brasileiros de cardiologia · 2024
    Guideline
  4. Pooled it
  5. Trial
  6. Influence ofAnnals of medicine · 2026
    Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Stable angina in young women.European heart journal · 2026
    Review
  16. Review
  17. Observational
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 17 institutions in 10 countries.

Eva GerdtsCenter for Research on Cardiac Disease in Women, University of Bergen, Bergen, Norway.ORCID 0000-0003-4109-2311
Isabella SudanoUniversity Hospital Zurich University Heart Center, Cardiology, University Hospital and University of Zurich, Zurich, Switzerland.ORCID 0000-0001-8197-8892
Sofie BrouwersDepartment of Cardiology, Cardiovascular Center Aalst, OLV Clinic Aalst, Aalst, Belgium.ORCID 0000-0002-7081-4881
Claudio BorghiDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.ORCID 0000-0001-8039-8781
Rosa Maria BrunoUniversité de Paris Cité, Inserm, PARCC, Paris, France.ORCID 0000-0002-6107-3356
Claudio CeconiUniversity of Cardiologia, ASST Garda, Desenzano del Garda, Italy.ORCID 0000-0002-6381-1404
Véronique CornelissenDepartment of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0002-0578-4954
François DiévartClinique Villette, Dunkerque, France.ORCID 0000-0001-6102-8494
Marc FerriniDepartment of Cardiology and Vascular Pathology, CH Saint Joseph and Saint Luc, Lyon, France.ORCID 0000-0002-2595-2433
Thomas KahanKarolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden.ORCID 0000-0001-9909-4956
Maja-Lisa LøchenDepartment of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-8532-6573
Angela H E M MaasDepartment of Cardiology, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0001-5782-9926
Felix MahfoudDepartment of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg/Saar, Germany.ORCID 0000-0002-4425-549X
Anastasia S MihailidouDepartment of Cardiology and Kolling Institute, Royal North Shore Hospital, St Leonards, UK.ORCID 0000-0001-6435-0411
Trine MoholdtDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0003-1024-8088
Gianfranco ParatiDepartment of Cardiac, Neural and Metabolic Sciences, Instituto Auxologico Italiano, IRCCS, Milan, Italy.ORCID 0000-0001-9402-7439
Giovanni de SimoneHypertension Research Center and Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.ORCID 0000-0001-8567-9881
Casa di Cura Villa Garda · ITCentre Hospitalier Saint-Joseph Saint-Luc · FRClinique du Millénaire · FRFederico II University Hospital · ITInserm · FRIRCCS Istituto Auxologico Italiano · ITKarolinska Institutet · SEKU Leuven · BENorwegian University of Science and Technology · NORadboud University Nijmegen · NLUiT The Arctic University of Norway · NOUniversitätsklinikum des Saarlandes · DEUniversity of Bergen · NOUniversity of Bologna · ITUniversity of Ulster · GBUniversity of Zurich · CHVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is strong evidence that sex chromosomes and sex hormones influence blood pressure (BP) regulation, distribution of cardiovascular (CV) risk factors and co-morbidities differentially in females and males with essential arterial hypertension. The risk for CV disease increases at a lower BP level in females than in males, suggesting that sex-specific thresholds for diagnosis of hypertension may be reasonable. However, due to paucity of data, in particularly from specifically designed clinical trials, it is not yet known whether hypertension should be differently managed in females and males, including treatment goals and choice and dosages of antihypertensive drugs. Accordingly, this consensus document was conceived to provide a comprehensive overview of current knowledge on sex differences in essential hypertension including BP development over the life course, development of hypertension, pathophysiologic mechanisms regulating BP, interaction of BP with CV risk factors and co-morbidities, hypertension-mediated organ damage in the heart and the arteries, impact on incident CV disease, and differences in the effect of antihypertensive treatment. The consensus document also highlights areas where focused research is needed to advance sex-specific prevention and management of hypertension.

Indexed as

HypertensionSex CharacteristicsFemaleHumansMaleAdverse eventsBlood Pressure regulatorsCardiovascular diseaseHypertensionHypertension-mediated organ damagePharmacological treatmentSexSex hormones

Identifiers

PMID36136303
PMCPMC9726450
OpenAlexW4296907726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.